Dimensional Fund Advisors’s Genesis Healthcare, Inc. GEN Stock Holding History

Dimensional Fund Advisors’s Portfolio GEN Stock Details GEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-12,117	Closed	-$14K	–	3346
2017 Q3	$14K	Sell	12,117 -402,995	-97%	-$508K	﹤0.01%	3331
2017 Q2	$722K	Sell	415,112 -133,492	-24%	-$284K	﹤0.01%	3042
2017 Q1	$1.45M	Sell	548,604 -20,102	-4%	-$72.2K	﹤0.01%	2896
2016 Q4	$2.42M	Buy	568,706 +47,744	+9%	+$157K	﹤0.01%	2773
2016 Q3	$1.39M	Buy	520,962 +41,078	+9%	+$94.5K	﹤0.01%	2864
2016 Q2	$849K	Sell	479,884 -30,506	-6%	-$62.2K	﹤0.01%	2961
2016 Q1	$1.18M	Sell	510,390 -26,056	-5%	-$58.9K	﹤0.01%	2887
2015 Q4	$1.86M	Sell	536,446 -15,668	-3%	-$75K	﹤0.01%	2830
2015 Q3	$3.38M	Sell	552,114 -33,871	-6%	-$230K	﹤0.01%	2662
2015 Q2	$3.87M	Sell	585,985 -94,069	-14%	-$635K	﹤0.01%	2660
2015 Q1	$4.84M	Buy	+680,054	New	+$5.13M	﹤0.01%	2566

Other funds holding GEN

CPA

Columbia Pacific Advisors Seattle, Washington $31M AUM 29.53% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

FWC

First Washington Corp Seattle, Washington $353M AUM 41.46% 1-Year Est. Return

PGCM

Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return

VCM

V3 Capital Management Dallas, Texas $33.4M AUM 5.9% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors's GEN Position: Q4 2017 in Review

Dimensional Fund Advisors sold out of Genesis Healthcare, Inc. (GEN) in Q4 2017, closing a stake of 12,117 shares — an estimated $14K sold.

Dimensional Fund Advisors first reported a position in GEN in Q1 2015 and held it in 11 quarters. The position peaked at $4.84M in Q1 2015. 68 funds tracked by Wall St. Rank hold GEN as of Q4 2017.

Dimensional Fund Advisors reported no remaining Genesis Healthcare, Inc. position as of Q4 2017 after selling out during the quarter.
Dimensional Fund Advisors sold 12,117 Genesis Healthcare, Inc. shares in Q4 2017, an estimated $14K.
Dimensional Fund Advisors first reported a position in Genesis Healthcare, Inc. in Q1 2015 and held it in 11 quarters.
Dimensional Fund Advisors's Genesis Healthcare, Inc. position peaked at $4.84M in Q1 2015.
68 funds tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q4 2017.

Based on Dimensional Fund Advisors's 13F filing for Q4 2017, filed 12 Feb 2018.